SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,499.17 -455.59
( -0.58%)

Global Indices

Nasdaq

53,904.84 -465.28
(-0.86%)

Dow Jones

7,729.00 -15.55
(-0.20%)

Hang Seng

65,597.55 -85.71
(-0.13%)

Nikkei 225

10,873.25 -15.05
(-0.14%)

Forex

USD-INR

95.07 -0.16
(-0.17%)

EUR-INR

109.74 0.07
(0.06%)

GBP-INR

127.99 0.00
(0.00%)

JPY-INR

0.60 0.00
(-0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Alembic Pharmaceuticals consolidated net profit rises 12.11% in the June 2026 quarter

Aug 04,2026

Net profit of Alembic Pharmaceuticals rose 12.11% to Rs 173.07 crore in the quarter ended June 2026 as against Rs 154.38 crore during the previous quarter ended June 2025. Sales rose 25.66% to Rs 2149.77 crore in the quarter ended June 2026 as against Rs 1710.72 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2149.77	1710.72	26
OPM %	15.44	16.42	-
PBDT	319.57	263.88	21
PBT	221.86	190.11	17
NP	173.07	154.38	12

78,499.17 -455.59 ( -0.58%)

53,904.84 -465.28 (-0.86%)

7,729.00 -15.55 (-0.20%)

65,597.55 -85.71 (-0.13%)

10,873.25 -15.05 (-0.14%)

95.07 -0.16 (-0.17%)

109.74 0.07 (0.06%)

127.99 0.00 (0.00%)

0.60 0.00 (-0.16%)